Trials / Completed
CompletedNCT02137993
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
A Multi-center, Randomized, Double Blind, Parallel, PhaseⅣ Trial to Evaluate the Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia, Schizophreniform Disorder and Schizoaffective Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of A-prexa compared to Zyprexa in patients with schizophrenia, schizophreniform disorder and schizoaffective disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A-prexa | A-prexa 5-20 mg for 6 weeks |
| DRUG | Zyprexa | Zyprexa 5-20 mg for 6 weeks |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2014-05-14
- Last updated
- 2014-05-14
Source: ClinicalTrials.gov record NCT02137993. Inclusion in this directory is not an endorsement.